Published in Prog Neuropsychopharmacol Biol Psychiatry on June 24, 2008
Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci (2010) 1.90
Imaging genetics of mood disorders. Neuroimage (2010) 1.06
Between destiny and disease: genetics and molecular pathways of human central nervous system aging. Prog Neurobiol (2010) 1.03
The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy. Mol Psychiatry (2015) 1.02
A functional polymorphism of the brain derived neurotrophic factor gene and cortical anatomy in autism spectrum disorder. J Neurodev Disord (2009) 0.96
Genetic patterns of correlation among subcortical volumes in humans: results from a magnetic resonance imaging twin study. Hum Brain Mapp (2011) 0.94
Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults. PLoS One (2012) 0.87
Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. J Neural Transm (Vienna) (2011) 0.86
Amygdala Volume in Offspring from Multiplex for Alcohol Dependence Families: The Moderating Influence of Childhood Environment and 5-HTTLPR Variation. J Alcohol Drug Depend (2013) 0.84
BDNF Val66Met polymorphism influences age differences in microstructure of the Corpus Callosum. Front Hum Neurosci (2009) 0.83
BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals. Transl Psychiatry (2011) 0.81
Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers. Neuroimage Clin (2013) 0.81
Brain-derived neurotrophic factor: its impact upon neuroplasticity and neuroplasticity inducing transcranial brain stimulation protocols. Neurogenetics (2014) 0.79
Involvement of the BDNF gene in loneliness in adolescence: a report of opposite gene effects in boys and girls. PLoS One (2014) 0.78
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis. Neurol Sci (2010) 0.78
Neurogenetic effects on cognition in aging brains: a window of opportunity for intervention? Front Aging Neurosci (2010) 0.78
Lack of association of SNPs from the FADS1-FADS2 gene cluster with major depression or suicidal behavior. Psychiatr Genet (2016) 0.76
Effects of the BDNF Val66Met Polymorphism on Gray Matter Volume in Typically Developing Children and Adolescents. Cereb Cortex (2016) 0.76
Effect of Bcl-2 rs956572 polymorphism on age-related gray matter volume changes. PLoS One (2013) 0.76
Fast robust automated brain extraction. Hum Brain Mapp (2002) 41.79
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell (2003) 12.50
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science (2006) 5.89
The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci (2004) 4.84
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp (2003) 4.34
Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cereb Cortex (2000) 3.73
Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci (2004) 3.47
BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry (2006) 2.79
BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci (2004) 2.76
Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci (2004) 2.73
Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. J Neurosci (2005) 2.44
The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging (2005) 2.39
Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography. Biol Psychiatry (2005) 2.16
Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet (2004) 2.13
Neurotrophin secretion: current facts and future prospects. Prog Neurobiol (2003) 2.12
Amygdala BDNF signaling is required for consolidation but not encoding of extinction. Nat Neurosci (2006) 2.10
A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology (2002) 2.07
Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry (2007) 2.05
Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) (2005) 1.77
BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology (2005) 1.74
Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry (2006) 1.59
Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res (1990) 1.54
The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Mol Psychiatry (2006) 1.46
Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J Neurosci (1993) 1.19
The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett (2006) 1.18
MRI volume of the amygdala: a reliable method allowing separation from the hippocampal formation. Psychiatry Res (1999) 1.13
Automatic segmentation of the brain and intracranial cerebrospinal fluid in T1-weighted volume MRI scans of the head, and its application to serial cerebral and intracranial volumetry. Magn Reson Med (2003) 1.11
The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression. Am J Geriatr Psychiatry (2008) 1.04
BDNF variant linked to anxiety-related behaviors. Bioessays (2007) 1.03
Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice. J Neural Transm (Vienna) (2006) 0.96
BDNF-modulated spatial organization of Cajal-Retzius and GABAergic neurons in the marginal zone plays a role in the development of cortical organization. Cereb Cortex (2005) 0.94
Expression profile of BDNF-responsive genes during cerebellar granule cell development. Biochem Biophys Res Commun (2006) 0.85
Volume reduction of the amygdala in patients with schizophrenia: a magnetic resonance imaging study. Psychiatry Res (2004) 0.84
Differential effects of NT-4, NGF and BDNF on development of neurochemical architecture and cell size regulation in rat visual cortex during the critical period. Eur J Neurosci (2007) 0.83
Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage (2009) 11.90
The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry (2011) 9.18
Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry (2007) 6.35
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA (2001) 4.34
Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex. Neurochem Res (2004) 4.33
Increased risk of suicide in persons with AIDS. JAMA (1988) 3.65
Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry (2006) 3.44
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A (2000) 3.34
Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry (2004) 3.19
The effect of kaolin on immunoglobulins: an improved technique to remove the nonspecific serum inhibitor of reovirus hemagglutination. J Immunol (1967) 3.17
Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron (2002) 3.06
Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. Am J Psychiatry (2011) 3.04
The anatomy of mood disorders--review of structural neuroimaging studies. Biol Psychiatry (1997) 2.86
Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology (2009) 2.63
Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry (2005) 2.54
Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A (1998) 2.54
Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disord (2012) 2.47
The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry (2013) 2.39
Evaluation of volume-based and surface-based brain image registration methods. Neuroimage (2010) 2.38
Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA (1993) 2.33
Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry (2006) 2.31
Ethnic and sex differences in suicide rates relative to major depression in the United States. Am J Psychiatry (2001) 2.26
Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J Neurosci (2011) 2.21
Prospective studies of suicidal behavior in major depressive and bipolar disorders: what is the evidence for predictive risk factors? Acta Psychiatr Scand (2006) 2.17
Protective factors against suicidal acts in major depression: reasons for living. Am J Psychiatry (2000) 2.17
Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography. Biol Psychiatry (2005) 2.16
Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis. Acta Psychiatr Scand (1996) 2.13
Influenza antibody in human respiratory secretions after subcutaneous or respiratory immunization with inactivated virus. Nature (1968) 2.10
Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine. JAMA (1969) 2.08
Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry (2005) 2.06
Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry (2005) 2.03
Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry (2001) 2.00
Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry (2009) 1.98
Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry (2006) 1.96
Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry (2003) 1.94
The effect of access to lethal methods of injury on suicide rates. Arch Gen Psychiatry (1992) 1.94
Antibody response in respiratory secretions of volunteers given live and dead influenza virus. J Immunol (1968) 1.92
Diagnostic stability of psychiatric disorders in clinical practice. Br J Psychiatry (2007) 1.88
Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res (1995) 1.85
Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry (2000) 1.82
Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology (2004) 1.82
Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry (2001) 1.80
Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry (2003) 1.79
Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry (2003) 1.78
Ecological studies of antidepressant treatment and suicidal risks. Harv Rev Psychiatry (2007) 1.78
Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry (2005) 1.77
Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions. J Cereb Blood Flow Metab (2000) 1.77
Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am J Psychiatry (2000) 1.75
Testosterone levels in suicide attempters with bipolar disorder. J Psychiatr Res (2012) 1.72
Antidepressants and suicide risk in the United States, 1985-1999. J Clin Psychiatry (2004) 1.72
Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res (2002) 1.71
Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology (2001) 1.71
A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res (2000) 1.67
Anxiety in major depression: relationship to suicide attempts. Am J Psychiatry (2000) 1.67
Suicidal behavior in patients with schizophrenia and other psychotic disorders. Am J Psychiatry (1999) 1.66
Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study. Am J Psychiatry (2000) 1.61
Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am J Psychiatry (2004) 1.60
Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab (2000) 1.56
Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. J Cereb Blood Flow Metab (2005) 1.55
Prevalence of recent cocaine use among motor vehicle fatalities in New York City. JAMA (1990) 1.52
Religious affiliation and suicide attempt. Am J Psychiatry (2004) 1.51
The relationship of childhood abuse to impulsivity and suicidal behavior in adults with major depression. Am J Psychiatry (2001) 1.49
An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology (2004) 1.49
Influenza virus neutralizing antibody in human respiratory secretions. J Immunol (1968) 1.48
Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology (2006) 1.45
Sex differences in clinical predictors of suicidal acts after major depression: a prospective study. Am J Psychiatry (2007) 1.45
Effect of exposure to suicidal behavior on suicide attempt in a high-risk sample of offspring of depressed parents. J Am Acad Child Adolesc Psychiatry (2010) 1.45
Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry (1997) 1.44
Suicide attempts and impulsivity. Eur Arch Psychiatry Clin Neurosci (2004) 1.43
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry (2000) 1.43
Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res (2007) 1.40
The functional neuroanatomy of mood disorders. J Psychiatr Res (1998) 1.40
Internally displaced "victims of armed conflict" in Colombia: the trajectory and trauma signature of forced migration. Curr Psychiatry Rep (2014) 1.39
Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom Med (1995) 1.38
Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters. J Affect Disord (2000) 1.36
Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction. BMC Bioinformatics (2003) 1.36
Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla. Eur J Pharmacol (1987) 1.36
Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J Neurochem (2003) 1.36
Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol (2005) 1.35
Fear conditioning drives profilin into amygdala dendritic spines. Nat Neurosci (2006) 1.35
Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology (2006) 1.35
Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology (2004) 1.33
Decreased regional brain metabolism after ect. Am J Psychiatry (2001) 1.33
Effect of acute alcohol use on the lethality of suicide attempts in patients with mood disorders. J Psychiatr Res (2009) 1.33
Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol Psychiatry (2010) 1.33
Is impulsivity a link between childhood abuse and suicide? Compr Psychiatry (2009) 1.31